Geron Corp (GERN) Halts Imetelstat Study in HER2-Negative Breast Cancer; Cits Median PFS in Phase 2
Go back to Geron Corp (GERN) Halts Imetelstat Study in HER2-Negative Breast Cancer; Cits Median PFS in Phase 2| Geron Corp (NASDAQ: GERN) | Delayed: 1.54 -0.03 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.57 | 52 Week High | $5.30 | |||
| Open | $1.57 | 52 Week Low | $1.81 | |||
| Day High | $1.61 | P/E | N/A | |||
| Day Low | $1.52 | EPS | $-0.35 | |||
| Volume | 940,369 | |||||
